FDA.reportPublic FDA data

fenofibrate 30 MG Oral Capsule [Antara]

RxCUI
1442165
RxNorm name
fenofibrate 30 MG Oral Capsule [Antara]
Display name
fenofibrate 30 MG Oral Capsule [Antara]
Full name
fenofibrate 30 MG Oral Capsule [Antara]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AntaraFENOFIBRATELupin Pharmaceuticals, Inc.12ebf783-64df-4ffa-9e84-f8fdf4d245d42024-08-20Warnings, Adverse reactionsExact identifier
rxcui: 1442165

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
12ebf783-64df-4ffa-9e84-f8fdf4d245d4Antara 30 MG Oral Capsule [PSN] · fenofibrate 30 MG Oral Capsule [Antara] [SBD] · Antara 30 MG Oral Capsule [SY]316These highlights do not include all the information needed to use ANTARA® safely and effectively. See full prescribing information for ANTARA. ANTARA (fenofibrate) capsules, for oral use Initial U.S. Approval: 199320240820